Schedule 13D/13G 大股東持股申報追蹤

任何投資人取得上市公司5%以上股權，都必須透過 Schedule 13D（具主動或控制意圖，通常是激進投資人）或 13G（被動投資）揭露——這往往是大股東動向最早的訊號。

申報數 (30天)

548

涉及公司數

具明確激進意圖

排行榜申報數

資料更新至 2026-07-15

最活躍個股 (30天)

代碼	公司名稱	申報數	最新激進意圖聲明	最後申報
PHUN	Phunware, Inc.	3	The Reporting Person acquired the shares of Common Stock reported herein for investment purposes. The Reporting Person intends to engage in discussions with the Company's board of directors and management regarding a range of matters, including, but not limited to, the Company's governance, capital allocation, strategic direction, and overall performance. In furtherance of the foregoing, the Reporting Person has recently initiated contact with members of the Company's board of directors to seek constructive dialogue and to improve the Company's governance, including through potential board representation. On July 9, 2026, the Reporting Person sent an Open Letter to the Board of Phunware setting forth the Reporting Person's views regarding corporate governance, shareholder representation, capital allocation and Board accountability. The Reporting Person believes that the Company's governance practices have materially contributed to prolonged operating losses, shareholder dilution, leadership instability and declining shareholder confidence. Based on the Company's operating and governance record during Mr Elliot Han's tenure as Chair, the Reporting Person has significant concerns regarding the Board's oversight, governance practices and capital allocation discipline. The Reporting Person also has concerns regarding the high compensation levels paid to each member of the Board. Based on the Company's public filings, Mr Han's cumulative compensation from Phunware is estimated to exceed USD 630,000 from January 2024 to now, more than USD 250,000 per year, during a period in which shareholder value has declined substantially. The Reporting Person believes that the Board's compensation levels are significantly higher than those of comparable micro cap public companies, and these compensation decisions are inconsistent with the Company's operating performance. The Reporting Person views this stark contrast as raising serious governance concerns. The Reporting Person believes that good governance requires accountability, and accountability requires shareholder representation. The Reporting Person believes meaningful governance reform is necessary. The Reporting Person also believes that the Company's current governance structure has failed to restore shareholder confidence despite repeated capital raises, prolonged operating losses, leadership turnover and significant destruction of shareholder value. Accordingly, meaningful Board refreshment is necessary to protect the interests of all shareholders. To strengthen the Board, the Reporting Person has proposed four potential director candidates: Shawn Kravetz, Richard Ding, Mona Zhang, and Steve Han. These individuals collectively bring extensive experience in corporate governance, capital allocation, business strategy, AI platform development, and business development. The Reporting Person proposed establishing a more balanced Board for Phunware. Specifically, it recommended expanding the Board and adding at least three new directors. The Reporting Person believes such expansion would improve shareholder representation and Board independence. If Mr. Elliot Han is no longer a member of the Board, the Reporting Person would be prepared to discuss alternative governance structures that may require fewer additional directors. Based on the parties' communications to date, the Reporting Person believes that the Board has not demonstrated a genuine willingness to consider meaningful governance improvements or changes to Board composition. Instead, the Board has declined to commit to any timetable for considering governance reforms or Board composition changes. In addition, rather than responding to the substantive governance issues raised by the Reporting Person, the Company's counsel has indicated that the Company may consider legal remedies if this Open Letter is published. The Reporting Person believes this response speaks for itself. The Reporting Person has repeatedly attempted to resolve these matters privately through discussions with the Board before considering public action. The Reporting Person sent more than 10 emails to Chairman Elliot Han over three months to request communication; he did not reply once. Rather than engaging directly with shareholders, the Board has consistently relied on the two counsel -not just one - to manage all email communications. The Board has never responded directly to any of emails or phone messages of the Reporting Person. The Reporting Person thinks this approach has unnecessarily hindered meaningful shareholder engagement and appears to prioritize protecting the existing Board over constructive communication with significant shareholders. If the parties are unable to reach a mutually acceptable resolution, the Reporting Person may nominate director candidates and conduct a proxy solicitation in connection with the Company's 2026 Annual Meeting. The Reporting Person is also evaluating the exercise of other shareholder rights available under applicable law, including the inspection of books and records. The Reporting Person remains willing to engage constructively with the Board if meaningful governance reforms are seriously considered. The Reporting Person believes that Phunware is undervalued and there are opportunities to enhance shareholder value through improved alignment, governance, and execution, and intends to continue to evaluate all available options to achieve such objectives. Depending on various factors, including, without limitation, market conditions, the Company's performance, and ongoing discussions with the Company and other shareholders, the Reporting Person may from time to time increase or decrease its beneficial ownership of the Company's securities, and may pursue various alternatives with respect to its investment, including engaging with other shareholders, seeking board representation, or pursuing other actions available to shareholders. The Reporting Person reserves the right to formulate and pursue any plans or proposals described in Item 4 of Schedule 13D, subject to applicable law. A copy of the Open Letter (Series 1) is attached hereto as Exhibit 99.1 and is incorporated herein by reference.	2026-07-14
EOSE	Eos Energy Enterprises, Inc.	2	Item 4 is hereby amended and supplemented by the addition of the following: On July 8, 2026, Gregory Nixon resigned from his role as a director on the Board of Directors (the "Board") of Eos Energy Enterprises, Inc. (the "Issuer"). Mr. Nixon had been appointed to the Board by CCM Denali Equity pursuant to the terms of the Series B Preferred Stock. In addition, on July 8, 2026, Nathaniel Fick resigned as a Class III director on the Board, and on July 8, 2026, pursuant to the terms of the Series B Preferred Stock, CCM Denali Equity elected Mr. Fick to the Board to replace Mr. Nixon as a designee of the holder of the Series B Preferred Stock. Mr. Fick will continue to serve on the Board's Nominating and Corporate Governance Committee.	2026-07-09
TBRG	TruBridge, Inc.	2	Item 4 is hereby amended to add the following: As previously disclosed, on April 23, 2026, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Inventurus Knowledge Solutions, Inc., a Delaware corporation ("Parent"), IKS Next Horizon, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), and solely for certain limited purposes as specified therein, Inventurus Knowledge Solutions Limited, an Indian public limited company. On July 9, 2026, pursuant to the terms and conditions of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), effective as of the effective time of the Merger (the "Effective Time"), with the Issuer continuing as the surviving corporation in the Merger and a wholly owned subsidiary of Parent. At the Effective Time, each Share owned by the Reporting Persons immediately prior to the Effective Time was automatically converted into the right to receive $26.25 per Share in cash, without interest (the "Per Share Merger Consideration"), pursuant to the Merger Agreement. Accordingly, as a result of the Merger, the Reporting Persons no longer beneficially own any securities of the Issuer.	2026-07-10
RPAY	Repay Holdings Corporation	2	On June 26, 2026 the Reporting Persons delivered a non-binding proposal (the "Proposal Letter") to the Board of Directors of the Issuer to offer to acquire all of the outstanding shares of the Issuer not already owned by the Reporting Persons at a price of $5.25 per share, payable in cash (the "Proposal"). The foregoing description of the Proposal Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the Proposal Letter, which is filed as Exhibit 99.6 hereto and is incorporated by reference into this Item 4. There can be no assurance that any discussions that may occur between the Reporting Persons and the Issuer with respect to the Proposal will result in the entry into a definitive agreement concerning a transaction or, if such a definitive agreement is reached, will result in the consummation of a transaction provided for in such definitive agreement. Discussions concerning a transaction may be terminated at any time and without prior notice. Entry into a definitive agreement concerning a transaction and the consummation of any such transaction will be subject to a number of contingencies that are beyond the control of the Reporting Persons, including the approval of the Board of Directors of the Issuer, and the satisfaction of any conditions to the consummation of a transaction set forth in any such definitive agreement.	2026-07-15
PERF	Perfect Corp.	2	As previously disclosed, on March 18, 2026, Ms. Alice H. Chang ("Ms. Chang") and her controlled affiliates GOLDEN EDGE CO., LTD. ("Golden Edge"), DVDonet.com. Inc. ("DVDonet") and World Speed Company Limited ("World Speed" and, together with Ms. Chang, Golden Edge and DVDonet, the "Chairwoman Parties"), and CyberLink International entered into a consortium agreement (the "Consortium Agreement") in connection with a proposed going-private transaction involving the Issuer. In connection with the Consortium Agreement, the Chairwoman Parties and CyberLink International submitted a preliminary non-binding proposal, dated March 18, 2026 (the "Proposal"), to the Issuer's board of directors to acquire all of the outstanding ordinary shares of the Issuer not owned by them for US$1.95 per ordinary share in cash. On July 10, 2026, the Chairwoman Parties and CyberLink International entered into a Termination Agreement (the "Consortium Termination Agreement"), pursuant to which the Consortium Agreement was terminated in its entirety and ceased to be of further force or effect. The Consortium Termination Agreement provides that, as of the date thereof, no party has any further rights or obligations under the Consortium Agreement and that CyberLink International will have no obligations with respect to the Transaction except as expressly set forth in the CyberLink Support Agreement (as defined below), the Consortium Termination Agreement or any other written agreement to which CyberLink International is a party in connection with the Transaction. On July 10, 2026, Merger Sub and the Issuer entered into the Merger Agreement. Pursuant to the Merger Agreement, and subject to the terms and conditions thereof, Merger Sub will merge with and into the Issuer, with the Issuer continuing as the Surviving Company. At the Effective Time, each Share, other than Dissenting Shares, Continuing Shares and Excluded Shares, will be cancelled in exchange for the right to receive US$2.00 in cash per Share, without interest. Each Continuing Share will not be cancelled in the Merger and will remain outstanding and continue to exist without interruption as one validly issued, fully paid and non-assessable ordinary share of the Surviving Company. The Continuing Shares held by the Chairwoman Parties and CyberLink International will constitute all of the issued and outstanding share capital of the Surviving Company immediately after the Effective Time. The Merger Agreement also provides for, among other things, the treatment of Company Options, Company Warrants and Company Earnout Shares, the delisting of the Issuer's Class A ordinary shares from the New York Stock Exchange and the deregistration of the Issuer's equity securities under the Act. On July 10, 2026, as an inducement to the Issuer's willingness to enter into the Merger Agreement, the Chairwoman Parties entered into a Voting and Support Agreement with Merger Sub (the "Chairwoman Support Agreement"). Pursuant to the Chairwoman Support Agreement, each Chairwoman Party agreed, among other things, (i) to vote all of its or her Securities in favor of the authorization and approval of the Merger Agreement, the Plan of Merger and the Transactions, including the Merger, subject to the terms and conditions set forth therein, (ii) to vote against certain competing or inconsistent transactions or actions, (iii) to comply with certain restrictions on transfers of its or her Securities, (iv) to waive appraisal or dissenters' rights with respect to its or her Securities and (v) that its or her Continuing Shares will not be cancelled in the Merger and will remain outstanding and continue to exist without interruption as ordinary shares of the Surviving Company. The Chairwoman Support Agreement provides that the Chairwoman Parties will receive no cash consideration for their Continuing Shares. On July 10, 2026, as an inducement to the Issuer's willingness to enter into the Merger Agreement, CyberLink International entered into a separate Voting and Support Agreement with Merger Sub (the "CyberLink Support Agreement" and, together with the Chairwoman Support Agreement, the "Support Agreements"). Pursuant to the CyberLink Support Agreement, CyberLink International agreed, among other things, (i) to vote all of its Securities in favor of the authorization and approval of the Merger Agreement, the Plan of Merger and the Transactions, including the Merger, subject to the terms and conditions set forth therein, (ii) to vote against certain competing or inconsistent transactions or actions, (iii) to comply with certain restrictions on transfers of its Securities, (iv) to waive appraisal or dissenters' rights with respect to its Securities and (v) that its Continuing Shares will not be cancelled in the Merger and will remain outstanding and continue to exist without interruption as ordinary shares of the Surviving Company. The CyberLink Support Agreement provides that CyberLink International will receive no cash consideration for its Continuing Shares. On July 10, 2026, Ms. Chang entered into a limited guarantee in favor of the Issuer (the "Limited Guarantee"), pursuant to which Ms. Chang guaranteed the due and punctual payment, observance, performance and discharge of certain payment obligations of Merger Sub under the Merger Agreement, including the Merger Sub Termination Fee and certain related collection costs and expenses, subject to the cap and other limitations set forth in the Limited Guarantee. If the Merger is completed, the Issuer's Class A ordinary shares would be delisted from the New York Stock Exchange, and the Issuer's obligation to file periodic reports under the Act would terminate. In addition, consummation of the Merger may result in one or more of the actions specified in clauses (a)-(j) of Item 4 of Schedule 13D, including the acquisition or disposition of securities of the Issuer, a merger or other extraordinary transaction involving the Issuer, a change to the board of directors of the Issuer, and changes to the Issuer's memorandum and articles of association to reflect that the Issuer would become a privately held company. Other than as described in this Item 4, none of the Reporting Persons currently has any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D. No assurance can be given that the Merger will be consummated. The information disclosed in this Item 4 does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement, the Consortium Termination Agreement, the Chairwoman Support Agreement, the CyberLink Support Agreement and the Limited Guarantee, each of which is filed as an exhibit hereto or incorporated herein by reference.	2026-07-10
JHG	JANUS HENDERSON GROUP PLC	2	Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: On June 30, 2026, the transactions contemplated by the Merger Agreement and the Equity Commitment Letter were consummated. As a result of the Merger, the Ordinary Shares will no longer be listed on The New York Stock Exchange and will be deregistered under Section 12(b) of the Exchange Act. Additionally, as a result of the Merger, MassMutual no longer beneficially owns any Ordinary Shares, though MassMutual retains an equity interest in the surviving company through its beneficial ownership of preferred equity interests of Topco.	2026-07-02
VMET	VERSAMET ROYALTIES CORPORATION	2	Item 4 is hereby amended and supplemented to add the following: Effective on June 25, 2026, Tether Investments transferred 8,870,456 Common Shares to Tether International, S.A. de C.V. (the "Transfer"). The Transfer resulted in no change in the aggregate number of Common Shares beneficially owned by the Reporting Persons.	2026-07-08
JCTC	JEWETT CAMERON TRADING CO LTD	2	The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. The Reporting Persons do not have any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - U) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position, results and strategic direction, actions taken by the Issuer's management team and the Issuer's board of directors (the "Board"), price levels of the Shares, conditions in the securities markets, general economic and industry conditions, and other investment opportunities available to the Reporting Persons, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in communications with management and the Board, engaging in discussions with the Issuer, stockholders of the Issuer or other third parties about the Issuer and the Reporting Persons' investment, including potential business combinations, dispositions or financing transactions involving the Issuer or certain of its businesses or assets, including transactions in which the Reporting Persons may seek to participate and potentially engage in, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, Board structure (including Board composition), or suggestions for improving the Issuer's financial and/or operational performance, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, including swaps and other derivative transactions, or changing their intention with respect to any and all matters referred to in Item 4.	2026-07-14
LFCR	LIFECORE BIOMEDICAL, INC. \DE\	2	Item 4 is hereby amended to add the following: The Reporting Persons are holders of shares of Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Stock"), of the Issuer, with rights as provided in the Certificate of Designations, Preferences, and Rights of Series A Convertible Preferred Stock of the Issuer (the "Certificate of Designations"). Section 8 of the of the Certificate of Designations, provides that from and after June 29, 2026, each holder of Series A Preferred Stock shall have the right to require that the Issuer redeem all or any portion of the conversion amount of such Holder's Series A Preferred Stock then outstanding, with such redemption to occur on the date which is the one hundred eightieth (180th) day, or the next business day if such date is not a business day, from the date the holder of Series A Preferred Stock gives notice to the Issuer. Any such redemption shall be pursuant to the terms of the Certificate of Designations. On June 30, 2026, the Reporting Persons submitted an optional redemption notice to the Issuer pursuant to Section 8 of the Certificate of Designations for 19,068.833524 shares of Series A Preferred Stock, plus all accrued and unpaid dividends, as well as all shares of Series A Preferred Stock paid as PIK dividends following June 30, 2026, representing the Reporting Persons' entire holdings of Series A Preferred Stock. The redemption date as set forth in the notice is December 28, 2026. Upon the occurrence of the redemption, the Reporting Persons' entire holdings of Series A Preferred Stock shall be purchased by the Issuer for cash and the Reporting Persons shall not hold any shares of Series A Preferred Stock. In its Form 10-Q filed May 6, 2026, the Issuer stated: "To make such cash redemption payments the Company would be required to obtain consent to such redemption payments or waiver of the restriction on cash dividends and/or redemptions set forth in each of the Company's credit agreements." 22NW believes that if the Issuer imposes this restriction on the redemption of its shares of Series A Preferred Stock it will be in contravention of the Certificate of Designations. 22NW intends to file a motion with the Supreme Court of the State of New York, County of New York to amend its outstanding Complaint against the Issuer and certain former directors and officers of the Issuer to, among other things, include a claim that when the Issuer entered into its current credit agreements in May 2023 it breached that certain Securities Purchase Agreement dated as of January 9, 2023, under which 22NW and other investors purchased the Series A Preferred Stock.	2026-07-02
ECHO	ECHOSTAR CORP	2	Item 4 is hereby amended and supplemented as follows: During the third quarter of each year, Mr. Ergen receives an annuity amount from the 2024 July GRAT, assuming that the 2024 July GRAT has not expired. The number of shares of Class B Common Stock to be distributed as an annuity payment is based in part on the price of the Class A Common Stock on the distribution date and therefore cannot be calculated until the date of distribution. In addition to shares of Class B Common Stock, the annuity payments (and their associated timing) may include, and be based upon, amounts generated from the holdings of the 2024 July GRAT including, among other things, stock recapitalizations or dividends paid or payable with respect to the shares of Class B Common Stock held by the 2024 July GRAT. On July 10, 2026, the 2024 July GRAT: (i) distributed 2,622,061 shares of Class B Common Stock held by the 2024 July GRAT to Mr. Ergen as an annuity payment; and (ii) contributed the remaining 15,939,781 shares of Class B Common Stock held by the 2024 July GRAT to Telluray Holdings, and the 2024 July GRAT expired in accordance with its terms. .	2026-07-14
BGDE	Big Digital Energy, Inc.	2	Item 4 is hereby amended to add the following: On June 30, 2026, Six Thirty AI purchased in a private placement 16,700 shares of the Issuer's Series D Convertible Preferred Stock ("Series D") with funds borrowed by Six Thirty AI from YA II PN, LTD, an investor otherwise unaffiliated with the Issuer. Six Thirty AI has the right to convert the Series D into Shares within 60 days of the date reflected on Amendment No. 10 to Schedule 13D filed with the SEC on July 2, 2026. The Series D and underlying Shares are pledged to YA II PN, LTD pursuant to a Loan and Guaranty Agreement dated June 30, 2026, and related agreements, and the Series D are exchangeable for the borrowed funds. The Conversion Price floats (95% of lowest daily VWAP in the five trading days prior to notice of conversion, with a floor price of $1.80 (20% of the closing price immediately prior to the initial closing), but there is a 19.99% cap on conversion until shareholder approval is obtained. The floating Conversion Price is otherwise subject to the terms and conditions established in the Certificate of Designations for the Series D Convertible Preferred Stock. Assuming the daily VWAP of a Share as of June 30, 2026 ($8.81) is used to calculate the Conversion Price, the Series D Convertible Preferred Stock would convert into 1,995,221 Shares.	2026-07-10
RYAM	RAYONIER ADVANCED MATERIALS INC.	2	Item 4 of the Initial Statement is hereby amended and restated as follows: On April 20, 2026, the Issuer announced that it is engaged in a formal process to explore strategic alternatives to maximize shareholder value. In connection therewith, the Reporting Persons entered into a standard confidentiality agreement with the Issuer, which includes customary "standstill" and other customary non-disclosure and non-use provisions. In this regard, if the Reporting Persons (or any of their affiliates) are invited to further participate in the strategic review process by the Issuer or the Board of Directors of the Issuer (the "Board") (or any committee thereof) or any of their respective representatives or advisors, the Reporting Persons expect that they (or one or more of their affiliates) are likely to do some or all of the following depending on how the process were to develop: -conduct due diligence on the Issuer and its subsidiaries; -subject to further due diligence and applicable internal approvals, submit one or more non-binding proposals (any such proposal, a "Proposal") to the Board (or any committee thereof) with respect to the acquisition of some or all of the Issuer's assets or shares or other transaction involving the Issuer, on terms and conditions to be set forth in any such proposal (any such transaction, a "Proposed Transaction"); -enter into discussions and negotiations with the Issuer and/or the Board (or any committee thereof), management of the Issuer and representatives and advisors of the foregoing with respect to any such Proposal(s) and any Proposed Transaction; and/or -enter into certain customary agreements (including engagement letters with financial advisors, financing sources or other consultants or advisors) relating to any such discussions. If the Reporting Persons (or one or more affiliates thereof) were to take any or more of the foregoing actions, they would be doing so pursuant to a process that is being managed and directed by the Board (and/or a committee thereof) and its representatives and advisors and the Reporting Persons are therefore putting the market on notice that they do not intend to amend this Schedule 13D if and when any such actions are taken pursuant to such process unless and until a definitive agreement has been reached with respect to a Proposed Transaction, or unless the Reporting Persons determine that such disclosure is otherwise required under applicable U.S. securities laws. The submission of a Proposal does not obligate in any way the Reporting Persons or the Issuer to negotiate or enter into definitive transaction documentation with respect to a transaction or otherwise complete a Proposed Transaction, and a binding commitment with respect to a Proposed Transaction will result only from the execution and delivery of definitive transaction documentation. Any definitive transaction documentation entered into in connection with a Proposed Transaction is likely to be subject to customary closing conditions. The Reporting Persons make no assurances that any definitive transaction agreement will be entered into with respect to a Proposed Transaction contemplated by a Proposal, or that a Proposed Transaction will be consummated even if the Issuer accepts any such Proposal and make no assurances as to the terms of any such transaction if one were to be consummated. Neither any Proposal nor this Amendment No. 1 is meant to be, nor should be construed as, an offer to buy or a solicitation of an offer to sell any of the Issuer's securities. If a Proposed Transaction is consummated, one or more of the transactions, events or actions specified in clauses (a) through (j) to the instructions of Item 4 of Schedule 13D may result, including, without limitation, an acquisition of additional securities of the Issuer, an extraordinary corporate transaction (such as a merger) involving the Issuer, other material changes in the Issuer's business or corporate structure, and the shares of the Common Stock would become eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act and would be delisted from the New York Stock Exchange. If a Proposed Transaction or similar transaction by unrelated parties is not consummated, the Reporting Persons may, at any time and from time to time, review, reconsider and/or change their position or purpose or formulate different plans or proposals with respect thereto. At any time and from time to time, the Reporting Persons may, in connection with monitoring and evaluating their investment in the Issuer, and after giving consideration to, among other things, any communications about the Issuer, market conditions, contractual restrictions, legal restrictions, the status of the review of strategic alternatives by the Board and/or other conditions, formulate a plan, proposal or other course of action which may relate to or result in, among other things and without limitation: (i) the purchase of additional or all shares of Common Stock, options or related derivatives in the open market, in privately negotiated transactions or otherwise; (ii) the sale of all or a portion of the shares of Common Stock, options or related derivatives now beneficially owned or hereafter acquired by them; (iii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; or (iv) any of the other matters referred to in the instructions to Item 4 of Schedule 13D. Any action taken by the Reporting Persons may be effected at any time and from time to time, subject to applicable limitations imposed by applicable law and any contractual limitations then applicable to the Reporting Persons.	2026-07-15
BZAI	Blaize Holdings, Inc.	2	The Reporting Persons acquired the securities of the Issuer for investment purposes. Reporting Persons or their affiliates may purchase additional securities or dispose of securities in varying amounts and at varying times depending upon Reporting Persons' continuing assessments of pertinent factors, including the availability of shares of Common Stock or other securities for purchase at particular price levels, the business prospects of the Issuer, other business investment opportunities, economic conditions, stock market conditions, money market conditions, the attitudes and actions of the board of directors (the "Board") and management of the Issuer, the availability and nature of opportunities to dispose of shares of the Issuer and other plans and requirements of the particular entities. The Reporting Persons may discuss items of mutual interest with the Issuer, which could include items in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Depending upon their assessments of the above factors, the Reporting Persons or their affiliates may change their present intentions as stated above and they may assess whether to make suggestions to the management of the Issuer regarding financing, and whether to acquire additional securities of the Issuer, including shares of Common Stock (by means of open market purchases, privately negotiated purchases, or otherwise) or to dispose of some or all of the securities of the Issuer, including shares of Common Stock, under their control. The Reporting Persons or their affiliates may seek to acquire other securities of the Issuer, including other equity, debt, notes or other financial instruments related to the Issuer or the Common Stock (which may include rights or securities exercisable or convertible into securities of the Issuer), and/or sell or otherwise dispose of some or all of such Issuer securities or financial instruments (which may include distributing some or all of such securities to such Reporting Person's respective partners or beneficiaries, as applicable) from time to time, in each case, in open market or private transactions, block sales or otherwise. Any transaction that any of the Reporting Persons or their affiliates may pursue may be made at any time and from time to time without prior notice and will depend on a variety of factors, including, without limitation, the price and availability of the Issuer's securities or other financial instruments, the Reporting Persons' or such affiliates' trading and investment strategies, subsequent developments affecting the Issuer, the Issuer's business and the Issuer's prospects, other investment and business opportunities available to such Reporting Persons and their affiliates, general industry and economic conditions, the securities markets in general, tax considerations and other factors deemed relevant by such Reporting Persons and such affiliates. The Reporting Persons intend to review their investment in the Issuer on an ongoing basis and, in the course of their review, may take actions (including through their affiliates) with respect to their investment or the Issuer, including communicating from time to time with the Board, members of management, other securityholders of the Issuer, or other third parties, advisors, such as legal, financial, regulatory, or other advisors, to assist in the review and evaluation of strategic alternatives. Such discussions and other actions may relate to various alternative courses of action, including, without limitation, those related to an extraordinary corporate transaction (including, but not limited to a merger, reorganization or liquidation) involving the Issuer or any of its subsidiaries; a sale or transfer of a material portion of the assets of the Issuer or any of its subsidiaries or the acquisition of material assets; the formation of joint ventures or other strategic alliances with the Issuer or any of its subsidiaries; changes in the present business, operations, strategy, future plans or prospects of the Issuer, financial or governance matters; changes to the Board or management of the Issuer; changes to the capitalization, ownership structure, dividend policy, business or corporate structure or governance documents of the Issuer; de-listing or de-registration of the Issuer's securities; or any action similar to the foregoing. Such discussions and actions may be exploratory in nature, and not rise to the level of a plan or proposal. Mr. Bess serves as Chairman of the Board and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Except as described in this Schedule 13D, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, although, subject to the agreements described herein, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans and may seek to influence management of the Issuer or the Board with respect to the business and affairs of the Issuer and may from time to time consider pursuing or proposing such matters with advisors, the Issuer or other persons.	2026-07-10
FRMI	Fermi Inc.	2	This amendment to the Schedule 13D/A filed on July 2, 2026 is being filed to correct a clerical error in the disclosure of the number of shares sold pursuant to the Option. The Reporting Persons originally acquired the Common Stock reported herein as a Co-Founder of the Issuer prior to the initial public offering of the Issuer. The dispositions of Common Stock reported on Schedule A resulted from the exercise of the Option, as described in Item 6. Certain founders of the Issuer, including Caddis, granted the Option in connection with the Issuer's Series C fundraising round prior to the Issuer's initial public offering to facilitate investor participation in that round and bolster the Issuer's fundraising efforts. The decision whether and when to exercise the Option rests with the holders of the Option and not with the Reporting Persons. The dispositions were not a decision by the Reporting Persons to reduce their investment in the Issuer. The Reporting Persons continue to beneficially own a substantial majority of their position and continue to support the Board, the Issuer's management team, and its long-term strategic plan. The Reporting Persons have had and anticipate having further communications with officers and directors of the Issuer in connection with the Reporting Persons' investment in the Issuer. Specifically, the Reporting Person issued a press release May 11, 2026 attached hereto as Exhibit 99.2 (the "Press Release") reaffirming the Reporting Persons' support for Fermi's Board of Directors (the "Board"), the Issuer's management team, and its long-term strategic plan. The Reporting Persons are actively and constructively engaged with the Board and management team to help the Issuer reach its full potential, including through ongoing discussions with strategic partners, advocating for rigorous capital allocation and best-in-class governance practices, and working collaboratively to maximize long-term value for our fellow shareholders, employees, customers, and other stakeholders. The Reporting Persons may also have similar conversations with other stockholders or other third parties, such as industry analysts, existing or potential strategic partners or competitors, investment professionals and other investors and may exchange information with any such persons or the Issuer pursuant to appropriate confidentiality or similar agreements (which may contain customary standstill provisions). The Reporting Persons may at any time reconsider and change their intentions relating to the foregoing. The Reporting Persons may also take one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D and may discuss or propose such actions with the Issuer's management and the Board, other stockholders of the Issuer and other third parties, such as those set out above. The Reporting Persons may also take steps to explore and prepare for various plans and actions, and propose transactions, before forming an intention to engage in such plans or actions or proceed with such transactions. The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer's financial position and strategic direction, the outcome of the discussions and matters referenced above, actions taken by the Issuer's management or Board, price levels of the Common Stock, liquidity requirements and other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take actions with respect to their investment position in the Issuer as they deem appropriate, including, without limitation, purchasing additional shares of Common Stock or other instruments that are based upon or relate to the value of the Common Stock or the Issuer in the open market or otherwise, selling some or all of the securities reported herein, and/or engaging in hedging or similar transactions with respect to the shares of Common Stock.	2026-07-08
GRAB	Grab Holdings Ltd	1	The information set forth in Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information thereto: On July 6, 2026, the Issuer announced that Dara Khosrowshahi, the Reporting Person's Chief Executive Officer, stepped down from the Issuer's board of directors (the "Board"), effective July 6, 2026. Following Mr. Khosrowshahi's resignation from the Board, the Reporting Person is not currently engaging in discussions with management of the Issuer, the Board, other shareholders of the Issuer or other relevant parties concerning the business, operations, board composition, management, strategy or control, or future plans of the Issuer that would reasonably be expected to result in any of the matters set forth in subparagraphs (a) through (j) of the instructions to Item 4 of Schedule 13D.	2026-07-08
LOCL	Local Bounti Corporation	1	Item 4 of the Schedule 13D is hereby amended and supplemented by inserting the following text at the end thereof: On July 2, 2026, Mr. Hurlbert sold 45,766 shares of the Issuer's Common Stock to cover tax withholding obligations in connection with the settlement of equity awards. The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction.	2026-07-02
DSS	DSS, INC.	1	On March 26, 2026 the Issuer issued a convertible promissory note (the "Convertible Promissory Note") to Alset International Limited in the amount of $2,450,000 which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest. On March 26, 2026 the Issuer issued common stock purchase warrants (the "Warrants") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share, which became exercisable on June 3, 2026. The Warrants expire on March 26, 2031.	2026-07-09
TSAT	Telesat Corporation	1	Item 4 is hereby amended and restated as follows. All of the Class B Shares reported on this Schedule 13D were acquired for investment purposes. The Reporting Persons intend to review their holdings in the Issuer on a continuing basis and as part of this ongoing review evaluate various alternatives that are or may become available with respect to the Issuer and its securities. Except as otherwise set forth in this Schedule 13D, neither the Reporting Persons nor, to the best of their knowledge, any of the other persons identified in response to Item 2 hereof, has any plans or proposals that relate to or would result in the occurrence of any of the transactions described in subparagraphs (b) through (j) of Item 4 of Schedule 13D. (a) The Reporting Persons may from time to time and at any time (in accordance with any trading policy of the Issuer or its subsidiaries and affiliates that may then be applicable to the Reporting Persons) in their sole discretion acquire, or cause to be acquired, additional equity or debt securities or other instruments of the Issuer, its subsidiaries or affiliates, or dispose, or cause to be disposed, such equity or debt securities or instruments, in any amount that the Reporting Persons may determine in their sole discretion, through public or private transactions or otherwise. The Reporting Persons reserve the right to and may, from time to time and at any time, in their sole discretion, formulate and implement other purposes, plans or proposals regarding the Issuer or any of its subsidiaries or affiliates or any of their equity or debt securities or instruments that relate to or would result in the occurrence of any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D as the Reporting Persons may deem advisable in their sole discretion. The information set forth in this Item 4 is subject to change from time to time and at any time, and there can be no assurances that any of the Reporting Persons will or will not take, or cause to be taken, any of the actions described above or any similar actions. Item 6 to this Schedule 13D is hereby incorporated by reference.	2026-07-09
STRR	Star Equity Holdings, Inc.	1	Item 4 is hereby amended to add the following: On June 25, 2026 Mr. Eberwein (the "Seller") entered into a Rule 10b5-1 of the Securities Exchange Act of 1934 ("Exchange Act") Sales Trading Plan ("10b5-1 Sales Plan") with Ladenburg Thalmann & Co. ("Broker") for the purpose of establishing a trading plan to effect sales of shares of Series A Cumulative Perpetual Preferred Stock, par value $0.001 per share, ("Preferred Stock") of the Issuer in compliance with all applicable laws, including, without limitation, Section 10(b) of the Exchange Act and the rules and regulations promulgated thereunder, including, but not limited to, Rule 10b5-1. The Broker is authorized to begin selling Preferred Stock pursuant to the 10b5-1 Sales Plan on October 1, 2026. The 10b5-1 Sales Plan expires on October 1, 2028, unless terminated earlier under certain conditions. There can be no assurance as to how many preferred shares, if any, will be sold pursuant to the 10b5-1 Sales Plan or at what price any such shares of Preferred Stock will be sold. The Seller may in the future modify, amend, suspend, or terminate the 10b5-1 Sales Plan in its sole discretion, and the Seller does not undertake any obligation to disclose any such modification, amendment, suspension, or termination. Notwithstanding, the Broker shall not sell Preferred Stock under the 10b5-1 Sales Plan, while the Broker is selling Preferred Stock as sales agent for the Issuer's ATM offering program. A copy of the 10b5-1 Sales Plan is attached hereto as Exhibit 99.2 and is incorporated herein by reference.	2026-06-29
LION	Lionsgate Studios Corp.	1	Item 4 is hereby amended and restated as follows. All of the Common Shares reported on this Schedule 13D were acquired for investment purposes. The Reporting Persons intend to review their holdings in the Issuer on a continuing basis and as part of this ongoing review to evaluate various alternatives that are or may become available with respect to the Issuer and its securities. Except as otherwise set forth in this Schedule 13D, neither the Reporting Persons nor, to the best of their knowledge, any of the other persons identified in response to Item 2 hereof, has any plans or proposals that relate to or would result in the occurrence of any of the transactions described in subparagraphs (b) through (j) of Item 4 of Schedule 13D. (a) The Reporting Persons may from time to time and at any time (in accordance with any trading policy of the Issuer or its subsidiaries and affiliates that may then be applicable to the Reporting Persons) in their sole discretion acquire, or cause to be acquired, additional equity or debt securities or other instruments of the Issuer, its subsidiaries or affiliates, or dispose, or cause to be disposed, such equity or debt securities or instruments, in any amount that the Reporting Persons may determine in their sole discretion, through public or private transactions or otherwise. The Reporting Persons reserve the right to and may, from time to time and at any time, in their sole discretion, formulate and implement other purposes, plans or proposals regarding the Issuer or any of its subsidiaries or affiliates or any of their equity or debt securities or instruments that relate to or would result in the occurrence of any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D as the Reporting Persons may deem advisable in their sole discretion. The information set forth in this Item 4 is subject to change from time to time and at any time, and there can be no assurances that any of the Reporting Persons will or will not take, or cause to be taken, any of the actions described above or any similar actions. Item 6 to this Schedule 13D is hereby incorporated by reference.	2026-07-09
RYES	Rise Gold Corp.	1	All securities of the Issuer that are beneficially owned by the reporting persons are held for investment purposes. Mr. Oliver intends to continue to seek to influence the policies of the Issuer with a goal of maximizing the value of the Issuer's common stock. Except as described above, the reporting persons have no plans or proposals that relate to, or could result in, any of the matters referred to in paragraphs (a) through (j) of Item 4 of Schedule 13D, except that, with respect to paragraph (d), Mr. Oliver may participate in making changes to the present board of directors in connection with the normal nominating process of the full board of directors for the Issuer's annual meetings of stockholders. The reporting persons may purchase common stock or sell or transfer common stock beneficially owned by them from time to time in private or public transactions depending on economic considerations. Any such transactions may be effected at any time or from time to time subject to any applicable limitations imposed on the purchase or sale of the common stock by applicable law.	2026-07-07
BOF	BranchOut Food Inc.	1	Item 4 of the Schedule 13D is hereby amended and supplemented as follows: Additional Loan. On June 30, 2026, the Issuer borrowed an additional $1,000,000 from Kaufman Kapital pursuant to a Third Amended and Restated Senior Secured Promissory Note in the principal amount of $4,000,000 (the "Amended Non-Convertible Note"), which amends and restates the Second Amended and Restated Senior Secured Promissory Note issued by the Issuer to Kaufman Kapital dated May 15, 2026. The Issuer disclosed the Additional Loan in a Current Report on Form 8-K filed on July 1, 2026. The Issuer stated in that Current Report that it intends to use the proceeds of the Additional Loan for working capital purposes for the production of customer orders. The Amended Non-Convertible Note matures on January 28, 2027 and bears interest at 8% per annum. The Amended Non-Convertible Note is not convertible into Common Stock and no equity securities, warrants, registration rights or other equity-linked consideration were issued to Kaufman Kapital in connection with the Additional Loan. The Amended Non-Convertible Note does not amend the conversion price, conversion ratio, underlying security, maturity date, beneficial ownership limitation or conversion mechanics of the Convertible Note. Share Sales. Following Amendment No. 5, Kaufman Kapital sold an aggregate of 55,000 shares of Common Stock in open market transactions pursuant to the Issuer's effective resale registration statement. Following such sales, the Reporting Persons' remaining direct common stock holdings consist of 445,000 shares acquired upon exercise of the $1.50 Warrant on May 7, 2026. Current Plans and Purposes. The Reporting Persons currently hold the securities of the Issuer for investment purposes. The Reporting Persons continuously evaluate their investment in the Issuer based on a variety of factors, including the Issuer's financial condition, results of operations, business prospects, general market and economic conditions, and other factors. Depending on such evaluation, the Reporting Persons may from time to time acquire additional securities of the Issuer, including through conversion of outstanding Convertible Note principal and accrued interest, subject to the Beneficial Ownership Limitation described below, dispose of some or all of the securities of the Issuer, including through open-market sales, privately negotiated transactions, block trades, registered offerings or otherwise, or take any other action with respect to their investment in the Issuer as they may deem appropriate. Any such transactions may be effected at any time and from time to time, subject to applicable law, and will depend upon a variety of factors, including those described above. Sales of directly held Common Stock may increase the number of shares issuable upon conversion of the Convertible Note that may be acquired without exceeding the Beneficial Ownership Limitation, without increasing the Reporting Persons' aggregate beneficial ownership above the Maximum Percentage. Except as otherwise described in this Amendment, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.	2026-07-02
BJRI	BJs RESTAURANTS INC	1	The Reporting Persons have engaged in transactions in the Common Shares of the Issuer as described in Item 5(c) of this Amendment. Such transactions consist primarily of sales of Common Shares effected in the ordinary course of managing the Reporting Persons investment in the Issuer. As a result of the transactions described herein, including the sales described in Item 5(c), the Reporting Persons have reduced their beneficial ownership of the Common Shares of the Issuer to below five percent of the outstanding Common Shares. Other than as described herein, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the matters described in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to formulate plans or proposals in the future with respect to the Issuer.	2026-07-01
TIGO	MILLICOM INTERNATIONAL CELLULAR SA	1	Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following: The information set forth in Item 3 of this Amendment No. 29 is incorporated herein by reference. On June 29, 2026, Atlas Investissement entered into a confirmation relating to an equity derivative transaction (the "June Equity Derivative Transaction" and the documentation relating thereto the "Equity Derivative Transaction Agreements") with an unaffiliated third party financial institution (the "Bank"), pursuant to which Atlas Investissement expects to purchase up to 6,000,000 Common Shares on or before September 29, 2026. The actual timing and the number of Common Shares under such transaction will be determined based on the hedging position of the Bank in accordance with certain parameters of the Equity Derivative Transaction Agreements. Under the terms of the Equity Derivative Transaction Agreements, absent any extraordinary event, Atlas Investissement will be obligated to pay the Bank in cash an amount defined under such agreements for the acquisition of a number of Common Shares determined in accordance with the terms of such agreements, in consideration of which the Bank will be obligated, at each relevant settlement date in accordance with the terms of such agreements, to deliver such number of such Common Shares. Cash dividends (relating to the Common Shares not having yet been delivered to Atlas Investissement under the Equity Derivative Transaction Agreements) paid during the term thereof will give rise to a payment by the Bank to Atlas Investissement for an amount determined (taking into account all relevant withholding taxes) in accordance with the Equity Derivative Transaction Agreements. All balances will be exclusively physically settled, absent any extraordinary event, at the scheduled settlement dates of the Equity Derivative Transaction Agreements, although Atlas Investissement has the right to request an earlier settlement date for a physical settlement relating to the entirety of the Bank's hedging position at the relevant time. The Equity Derivative Transaction Agreements provide that Atlas Investissement does not have any direct or indirect voting, investment or dispositive control over any of the Common Shares held by the Bank corresponding to its hedging position until a settlement and delivery of such shares to Atlas Investissement and that the Bank will not notify or consult with Atlas Investissement regarding any voting rights with respect to the Common Shares that relate to its hedging position. The foregoing description of the June Equity Derivative Transaction is qualified in its entirety by reference to the terms of the Confirmation relating to the June Equity Derivative Transaction, a copy of which is filed as exhibit to this Amendment No. 29 and incorporated herein by reference. Separately from the above, on June 26, 2026, Atlas Investissement has irrevocably elected cash settlement for the three European-style call spread option transactions contemplated under each of the respective Letter Agreements on Share Option Transaction (as defined and described in Amendment No. 21 to the Schedule 13D).	2026-06-29
SHMD	SCHMID Group N.V.	1	The information set forth in Item 3 of this Schedule 13D/A is incorporated herein by reference. All of the Ordinary Shares reported herein as beneficially owned by the Reporting Persons were acquired in connection with the Business Combination, subsequent allocation and contribution of such Ordinary Shares to HoldCos, and the off-set of debts owed by Issuer group companies, and in exchange for the work of Anette and Christian Schmid in their capacities as employees and board members of the Issuer. On May 14, 2026, the Reporting Persons effected an transfers pursuant to which Ordinary Shares held by Anette Schmid and Christian Schmid, including shares distributed from the Erbengemeinschaft, were contributed to and are now directly held by Schmid Aequitas GmbH & Co. KG and C. Schmid Beteiligung GmbH & Co. KG, respectively. In addition, the economic interests in certain Earn-Out Shares and warrants were allocated to such entities through arrangements intended to transfer the economic benefits of such securities, including through trustee or nominee structures where direct legal ownership could not be transferred. These transactions were undertaken for estate planning, organizational and tax structuring purposes and did not involve the payment of cash consideration. On May 23, 2026 Ordinary Shares were issued to Anette Schmid, Christian Schmid and Schmid Grundstucke GmbH & Co KG, in exchange for the off-set of debts owed by Issuer group companies, and the work of Anette and Christian Schmid in their capacities as employees and board members of the Issuer (details are set forth in Item 3). Some shares received by Anette Schmid and Christian Schmid were transferred by them to their respectively controlled HoldCos, some are still held by each directly, and Anette Schmid beneficially owns the securities issued to Schmid Grundstucke GmbH & Co KG, which is an investment vehicle she controls. On May 18, 2026, the Reporting Persons entered into a Joint Voting Agreement pursuant to which they agreed to vote or cause to be voted all Ordinary Shares beneficially owned by them in accordance with a joint determination. As a result of such agreement, the Reporting Persons may be deemed to constitute a "group" within the meaning of Section 13(d)(3) of the Act, and, accordingly, may be deemed to beneficially own the securities beneficially owned by each other Reporting Person. On May 26, 2026 Schmid Grundstucke GmbH & Co KG joined the Joint Voting Agreement and is subsequently subject to all its conditions. On July 3, 2026 Christian Schmid contracted under a German law gift contract to transfer 500,000 Ordinary Shares owned by him to Helmut Rauch, an employee and management member of Gebr. Schmid GmbH, for no consideration. Anette Schmid and Christian Schmid currently serve on the board of directors of the Issuer, and Christian Schmid also serves as Chief Executive Officer of the Issuer. As a result of their direct and indirect ownership of Ordinary Shares and their positions with the Issuer, the Reporting Persons have the ability to influence the management and policies of the Issuer. The Reporting Persons intend to hold their respective interests in the Issuer for investment purposes and to support the ongoing management and operation of the Issuer. Except as described herein, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the transactions or other matters described in clauses (a) through (j) of Item 4 of Schedule 13D, although the Reporting Persons may, from time to time, review their investment in the Issuer and, subject to applicable law, may determine to increase or decrease their ownership position or to pursue or consider other plans or proposals relating to the Issuer.	2026-07-08

代碼	申報人	類型	申報日期	持股數	持股比例
WULF	BANK OF NOVA SCOTIA	13G/A	2026-07-15	39.82M	7.7%
DDD	BANK OF NOVA SCOTIA	13G/A	2026-07-15	5.25M	3.2%
CHMG	CHEMUNG CANAL TRUST CO	13G/A	2026-07-15	305K	6.3%
FRPT	Wasatch Advisors LP	13G/A	2026-07-15	2.82M	5.7%
GSHD	Wasatch Advisors LP	13G/A	2026-07-15	1.89M	8.0%
HQY	Wasatch Advisors LP	13G/A	2026-07-15	7.96M	9.5%
ICFI	Wasatch Advisors LP	13G/A	2026-07-15	578K	3.2%
DERM	Wasatch Advisors LP	13G/A	2026-07-15	2.86M	13.3%
KAI	Wasatch Advisors LP	13G/A	2026-07-15	869K	7.4%
LMB	Wasatch Advisors LP	13G/A	2026-07-15	381K	3.2%
NXTS	Lee Eun Young	13G/A	2026-07-15	47K	3.2%
MCHP	Invesco Ltd.	13G/A	2026-07-15	26.54M	4.9%
PATH	Westbourne River Event Master Fund	13G/A	2026-07-15	30.95M	6.8%
GFUZ	RichRich Capital LLC	13G/A	2026-07-15	0	0.0%
DFSC	Lind Global Fund III LP	13G/A	2026-07-15	140K	5.0%
RYAM	Lightship Capital III LP	13D/A	2026-07-15	3.40M	5.0%
GLOB	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	3.86M	8.9%
HOFT	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	1.54M	14.4%
AVT	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	3.23M	3.9%
DOX	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	14.20M	13.2%
CRBG	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	34.21M	7.7%
MGA	PZENA INVESTMENT MANAGEMENT LLC	13G/A	2026-07-15	24.43M	8.8%
ELPW	L1 Capital Global Opportunities Master Fund, Ltd.	13G/A	2026-07-15	1.61M	10.0%
GLBS	FIRMENT SHIPPING INC.	13D/A	2026-07-15	6.58M	30.5%
PRQR	STICHTING AESCAP LIFE SCIENCES	13G/A	2026-07-15	5.53M	5.2%
NWSA	Perpetual Limited	13G/A	2026-07-15	8.31M	4.5%
NWSA	Perpetual Investment Management Limited	13G/A	2026-07-15	8.02M	4.4%
MTA	Tether Global Investments Fund, S.I.C.A.F., S.A.	13D/A	2026-07-15	12.59M	13.5%
BBCQ	Millennium Management LLC	13G/A	2026-07-15	805K	2.8%
KIDS	Integrated Core Strategies (US) LLC	13G/A	2026-07-15	817K	3.2%
NNOX	Moalem Moshe	13G/A	2026-07-15	5.26M	7.6%
MS	MITSUBISHI UFJ FINANCIAL GROUP, INC.	13D/A	2026-07-15	380.51M	24.1%
BRK-B	Warren E. Buffett	13D/A	2026-07-15	188K	38.2%
RPAY	BT Parent GP, LLC	13D/A	2026-07-15	8.91M	9.4%
FULC	TANG CAPITAL MANAGEMENT, LLC	13G/A	2026-07-15	6.91M	10.4%
SERA	Aberdeen Group plc	13G/A	2026-07-15	2.75M	7.2%
Franklin BSP Lending Fund	FRANKLIN RESOURCES INC	13D/A	2026-07-14	75K	55.6%
AOSL	Dimensional Fund Advisors LP	13G/A	2026-07-14	1.34M	4.5%
SIG	Dimensional Fund Advisors LP	13G/A	2026-07-14	2.58M	6.6%
DHT	Dimensional Fund Advisors LP	13G/A	2026-07-14	10.03M	6.2%
ASO	Dimensional Fund Advisors LP	13G/A	2026-07-14	4.09M	6.6%
BAND	Dimensional Fund Advisors LP	13G/A	2026-07-14	938K	3.1%
BHE	Dimensional Fund Advisors LP	13G/A	2026-07-14	2.23M	6.2%
BHF	Dimensional Fund Advisors LP	13G/A	2026-07-14	3.63M	6.3%
CERT	Dimensional Fund Advisors LP	13G/A	2026-07-14	6.02M	3.9%
CLSK	Dimensional Fund Advisors LP	13G/A	2026-07-14	9.65M	3.8%
CLW	Dimensional Fund Advisors LP	13G/A	2026-07-14	1.06M	6.6%
DXC	Dimensional Fund Advisors LP	13G/A	2026-07-14	8.06M	5.0%
ECVT	Dimensional Fund Advisors LP	13G/A	2026-07-14	6.59M	6.0%
EPC	Dimensional Fund Advisors LP	13G/A	2026-07-14	1.86M	4.0%
FWRG	Dimensional Fund Advisors LP	13G/A	2026-07-14	2.60M	4.2%
KN	Dimensional Fund Advisors LP	13G/A	2026-07-14	5.02M	5.9%
M	Dimensional Fund Advisors LP	13G/A	2026-07-14	16.80M	6.4%
VAC	Dimensional Fund Advisors LP	13G/A	2026-07-14	1.55M	4.5%
MCFT	Dimensional Fund Advisors LP	13G/A	2026-07-14	1.05M	4.3%
MBC	Dimensional Fund Advisors LP	13G/A	2026-07-14	9.20M	4.5%
NAVI	Dimensional Fund Advisors LP	13G/A	2026-07-14	5.31M	5.6%
DNOW	Dimensional Fund Advisors LP	13G/A	2026-07-14	7.96M	4.4%
PHIN	Dimensional Fund Advisors LP	13G/A	2026-07-14	2.36M	6.4%
RYAM	Dimensional Fund Advisors LP	13G/A	2026-07-14	3.30M	4.9%

常見問題

什麼是 Schedule 13D 和 Schedule 13G？

兩者都是投資人取得上市公司5%以上表決權股份時必須向 SEC 申報的揭露文件。Schedule 13D 適用於具有主動或控制意圖的投資人（通常是激進投資人），必須詳細揭露其意圖；Schedule 13G 則是給被動型機構投資人（指數基金、共同基金）的簡化申報，代表無意介入公司經營權。

為什麼 13D 比 13G 更容易成為股價的重大訊號？

13D 申報通常代表激進投資人有所行動——爭取董事席次、推動公司出售、或要求策略轉向。文件中的 Item 4（交易目的）會明確寫出其意圖，足以牽動股價。13G 申報人通常是被動投資，較不會單獨引發市場反應。

13D/A 或 13G/A 這類修正申報代表什麼？

修正申報是對先前 13D 或 13G 的更新——例如持股比例變動、新增意圖聲明、或某位聯合申報成員退出申報團體。我們會保留每一次修正作為獨立紀錄，並標記每個申報團體最新的一筆作為目前持股狀態。

為什麼有些申報看不到持股數？

2024年12月18日 SEC 結構化 XML 規定生效前的申報，有些只包含表頭層級的身分資料，沒有機器可讀的持股數字。我們仍會顯示這些申報，但持股數與比例欄位會留空，而不會用猜測的數字填補。

這份資料的即時性如何？

每日從 SEC EDGAR 抓取新申報。由於申報內容一旦提交就不會改變，加上規定必須在跨過5%門檻後10天內申報，本追蹤器通常能在公開揭露後一到兩天內反映持股變化。

13D/13G 資料該如何搭配 13F 機構申報一起解讀？

13F 顯示的是機構每季彙總的持倉；13D/13G 則是特定投資人跨過5%門檻的近即時揭露，13D 申報人還會附上明確意圖。兩者搭配使用，有助於區分「指數基金的例行再平衡」與「單一投資人的刻意集中下注」。

Schedule 13D/13G 大股東持股申報追蹤

最活躍個股 (30天)

最新 13D/13G 申報

常見問題